EDBT 2026 Demo / reviewers in the wild / expert
Amaya Gallagher-Syed
dblp:357/0252
· DBLP profile ↗
3ranked-venue papers
2as first author
3since 2021 · last 2025
0000-0002-6253-3174ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 3 · 2 first-author · 3 since 2021Graphics, computer vision, multimedia, augmented reality and games · 2 · 2 first-author · 2 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Artificial intelligence
2 papers |
Trustworthy machine learning · 54% Graph learning · 23% Deep learning architectures and training · 23% | |
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Medical and health informatics · 50% Bioinformatics and computational biology · 50% |
Topics — the 8 heaviest of 9, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Machine learning › Deep learning architectures and training
foundation model |
0.9 | 1 | 2025 | PertEval-scFM: Benchmarking Single-Cell Foundation Models for Perturbation Effect Prediction · ICML 2025 |
Machine learning › Graph learning
graph neural network |
0.9 | 1 | 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational Pathology · CVPR 2025 |
Machine learning › Trustworthy machine learning › interpretability
graph neural network explanation |
0.9 | 1 | 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational Pathology · CVPR 2025 |
Machine learning › Trustworthy machine learning
interpretability |
0.9 | 1 | 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational Pathology · CVPR 2025 |
Bioinformatics and computational biology › genomics
computational genomics |
0.9 | 1 | 2025 | PertEval-scFM: Benchmarking Single-Cell Foundation Models for Perturbation Effect Prediction · ICML 2025 |
Medical and health informatics
computational pathology |
0.9 | 1 | 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational Pathology · CVPR 2025 |
Bioinformatics and computational biology › systems biology
perturbation effect prediction |
0.9 | 1 | 2025 | PertEval-scFM: Benchmarking Single-Cell Foundation Models for Perturbation Effect Prediction · ICML 2025 |
Medical and health informatics › computational pathology › histopathology image analysis › whole slide image analysis
whole slide image classification |
0.9 | 1 | 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational Pathology · CVPR 2025 |
Methods — techniques the papers use, named apart from their topics
zero-shot evaluation · 1.7multistain analysis · 1.7graph neural network · 1.7embedding-based prediction · 1.7attention pooling · 1.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | BioX-CPath: Biologically-driven Explainable Diagnostics for Multistain IHC Computational PathologyabstractThe development of biologically interpretable and explainable models remains a key challenge in computational pathology, particularly for multistain immunohistochemistry (IHC) analysis. We present BioX-CPath, an explainable graph neural network architecture for whole slide image (WSI) classification that leverages both spatial and semantic features across multiple stains. At its core, BioX-CPath introduces a novel Stain-Aware Attention Pooling (SAAP) module that generates biologically meaningful, stain-aware patient embeddings. Our approach achieves state-of-the-art performance on both Rheumatoid Arthritis and Sjogren’s Disease multistain datasets. Beyond performance metrics, BioX-CPath provides interpretable insights through stain attention scores, entropy measures, and stain interaction scores, that permit measuring model alignment with known pathological mechanisms. This biological grounding, combined with strong classification performance, makes BioX-CPath particularly suitable for clinical applications where interpretability is key. Source code and documentation can be found at: https://github.com/AmayaGS/BioX-CPath. Amaya Gallagher-Syed, Henry Senior, Omnia Alwazzan, Elena Pontarini, Michele Bombardieri, Costantino Pitzalis, Myles J. Lewis, Michael R. Barnes, Luca Rossi 0011, Gregory Slabaugh |
CVPR | 1 |
| 2025 | PertEval-scFM: Benchmarking Single-Cell Foundation Models for Perturbation Effect Predictionabstract*In silico* modeling of transcriptional responses to perturbations is crucial for advancing our understanding of cellular processes and disease mechanisms. We present PertEval-scFM, a standardized framework designed to evaluate models for perturbation effect prediction. We apply PertEval-scFM to benchmark zero-shot single-cell foundation model (scFM) embeddings against baseline models to assess whether these contextualized representations enhance perturbation effect prediction. Our results show that scFM embeddings offer limited improvement over simple baseline models in the zero-shot setting, particularly under distribution shift. Overall, this study provides a systematic evaluation of zero-shot scFM embeddings for perturbation effect prediction, highlighting the challenges of this task and the limitations of current-generation scFMs. Our findings underscore the need for specialized models and high-quality datasets that capture a broader range of cellular states. Source code and documentation can be found at: https://github.com/aaronwtr/PertEval. Aaron Wenteler, Martina Occhetta, Nikhil Branson, Victor Curean, Magdalena Huebner, William Dee, William Connell, Siu Pui Chung, Alex Hawkins-Hooker, Yasha Ektefaie, César Miguel Valdez Córdova, Amaya Gallagher-Syed |
ICML | 12 |
| 2023 | Multi-Stain Self-Attention Graph Multiple Instance Learning Pipeline for Histopathology Whole Slide Images
Amaya Gallagher-Syed, Luca Rossi 0011, Felice Rivellese, Costantino Pitzalis, Myles J. Lewis, Michael R. Barnes, Gregory Slabaugh |
BMVC | 1 |